220 related articles for article (PubMed ID: 34498424)
1. Identification of a novel six-gene signature with potential prognostic and therapeutic value in cervical cancer.
Qu X; Shi Z; Guo J; Guo C; Qiu J; Hua K
Cancer Med; 2021 Oct; 10(19):6881-6896. PubMed ID: 34498424
[TBL] [Abstract][Full Text] [Related]
2. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification.
Sun K; Huang C; Li JZ; Luo ZX
World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777
[TBL] [Abstract][Full Text] [Related]
3. Identification and Validation of the Anoikis-Related Gene Signature as a Novel Prognostic Model for Cervical Squamous Cell Carcinoma, Endocervical Adenocarcinoma, and Revelation Immune Infiltration.
Jin QQ; Mei J; Hong L; Wang R; Wu SY; Wang SL; Jiang XY; Yang YT; Yao H; Zhang WY; Zhu YT; Ying J; Tian L; Chen G; Zhou SG
Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837559
[No Abstract] [Full Text] [Related]
4. A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
Liu J; Wu Z; Wang Y; Nie S; Sun R; Yang J; Cheng W
Int Immunopharmacol; 2020 Nov; 88():106884. PubMed ID: 32795900
[TBL] [Abstract][Full Text] [Related]
5. A novel prognostic signature based on cancer stemness and metabolism-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
Wang Y; Han Y; Jin L; Ji L; Liu Y; Lin M; Zhou S; Yang R
Aging (Albany NY); 2024 Apr; 16(8):7293-7310. PubMed ID: 38656879
[TBL] [Abstract][Full Text] [Related]
6. Identifying a cervical cancer survival signature based on mRNA expression and genome-wide copy number variations.
Li N; Yu K; Lin Z; Zeng D
Exp Biol Med (Maywood); 2022 Feb; 247(3):207-220. PubMed ID: 34674573
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of lymph nodes metastasis associated genes in cervical cancer and its significance in treatment and prognosis.
Yang P; Ruan Y; Yan Z; Gao Y; Yang H; Wang S
BMC Cancer; 2021 Nov; 21(1):1230. PubMed ID: 34789197
[TBL] [Abstract][Full Text] [Related]
8. Immunogenomic Identification for Predicting the Prognosis of Cervical Cancer Patients.
Wang Q; Vattai A; Vilsmaier T; Kaltofen T; Steger A; Mayr D; Mahner S; Jeschke U; Hildegard Heidegger H
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671013
[TBL] [Abstract][Full Text] [Related]
9. A Novel Eight-Gene Signature for Lipid Metabolism Predicts the Progression of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.
Wang S; Zhang S
Reprod Sci; 2024 Feb; 31(2):514-531. PubMed ID: 37749448
[TBL] [Abstract][Full Text] [Related]
10. Identification of a six-gene prognostic signature for oral squamous cell carcinoma.
Wang J; Wang Y; Kong F; Han R; Song W; Chen D; Bu L; Wang S; Yue J; Ma L
J Cell Physiol; 2020 Mar; 235(3):3056-3068. PubMed ID: 31538341
[TBL] [Abstract][Full Text] [Related]
11. Identification of an autophagy-related gene signature for survival prediction in patients with cervical cancer.
Chen H; Deng Q; Wang W; Tao H; Gao Y
J Ovarian Res; 2020 Nov; 13(1):131. PubMed ID: 33160404
[TBL] [Abstract][Full Text] [Related]
12. A novel DNA damage repair-related gene signature predicting survival, immune infiltration and drug sensitivity in cervical cancer based on single cell sequencing.
Xiang X; Kang J; Jiang J; Zhang Y; Zhang Y; Li L; Peng X
Front Immunol; 2023; 14():1198391. PubMed ID: 37449209
[TBL] [Abstract][Full Text] [Related]
13. Construction of an immune-related gene signature for prediction of prognosis in patients with cervical cancer.
Mei J; Xing Y; Lv J; Gu D; Pan J; Zhang Y; Liu J
Int Immunopharmacol; 2020 Nov; 88():106882. PubMed ID: 32799114
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of tumour microenvironment-related genes by TCGA database in rectal cancer.
Li C; Liu T; Liu Y; Zhang J; Zuo D
J Cell Mol Med; 2021 Jun; 25(12):5811-5822. PubMed ID: 33949771
[TBL] [Abstract][Full Text] [Related]
15. A Five-Genes-Based Prognostic Signature for Cervical Cancer Overall Survival Prediction.
Zhao M; Huang W; Zou S; Shen Q; Zhu X
Int J Genomics; 2020; 2020():8347639. PubMed ID: 32300605
[No Abstract] [Full Text] [Related]
16. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
[TBL] [Abstract][Full Text] [Related]
17. Construction of a ferroptosis and hypoxia-related gene signature in cervical cancer to assess tumour immune microenvironment and predict prognosis.
Wu H; Fan Y; Bao Y; Zhou Q; Xu L; Xu Y
J Obstet Gynaecol; 2024 Dec; 44(1):2321323. PubMed ID: 38425023
[TBL] [Abstract][Full Text] [Related]
18. A Novel Immune-Related Seventeen-Gene Signature for Predicting Early Stage Lung Squamous Cell Carcinoma Prognosis.
Fan T; Lu Z; Liu Y; Wang L; Tian H; Zheng Y; Zheng B; Xue L; Tan F; Xue Q; Gao S; Li C; He J
Front Immunol; 2021; 12():665407. PubMed ID: 34177903
[TBL] [Abstract][Full Text] [Related]
19. Immune infiltration and a necroptosis-related gene signature for predicting the prognosis of patients with cervical cancer.
Xing X; Tian Y; Jin X
Front Genet; 2022; 13():1061107. PubMed ID: 36685937
[No Abstract] [Full Text] [Related]
20. A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma.
Song D; Tian J; Han X; Li X
Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3467-3477. PubMed ID: 33449165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
